NASDAQ:ORGS Orgenesis Q1 2024 Earnings Results & Report $0.0004 -0.07 (-99.43%) As of 11:07 AM Eastern Orgenesis reported Q1 2024 earnings on May 21, 2024. The company reported EPS of -$2.90, while revenue was $0.14 million. Research:Profile Earnings Announcement Details QuarterQ1 2024Report DateMay 21, 2024 Orgenesis EPS ResultsActual EPS-$2.90Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/AEPS Beat Rate2 of last 4 quartersOrgenesis Revenue ResultsActual Revenue$0.14 millionExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AUpcoming EarningsOrgenesis' next earnings date is estimated for Wednesday, November 11, 2026, based on past reporting schedules. Conference Call ResourcesCompany Profile Orgenesis Q1 2024 Earnings FAQ Did Orgenesis beat earnings estimates for Q1 2024? Orgenesis (NASDAQ:ORGS) reported earnings of -$2.90 per share for Q1 2024. The report was announced on Tuesday, May 21, 2024. What was Orgenesis' revenue for Q1 2024? Orgenesis reported revenue of $0.14 million for Q1 2024. When is Orgenesis' next earnings date? Orgenesis' next earnings date is estimated for Wednesday, November 11, 2026. MarketBeat tracks confirmed and estimated earnings dates for Orgenesis on the company's earnings history page. Orgenesis Earnings HeadlinesOrgenesis (NASDAQ:ORGS) Stock Falls 5.2% - Here's What HappenedOctober 6, 2026 | americanbankingnews.comOrgenesis Shareholders Approve Major Charter and Stock IncreaseJune 4, 2026 | theglobeandmail.comElon pays this company. Every time.Every Tesla built since 2012 pays this small, overlooked supplier a fee for its technology. So does every Starlink dish and AI satellite Elon launches. When Nvidia tried to buy the company, Elon reportedly fought the deal. Now his filing for 1,000,000 satellites could expand its revenue stream sharply. Dylan believes the stock could see significant movement starting October 24th.October 14 at 1:00 AM | Behind the Markets (Ad)Orgenesis Issues Alpha Warrant in New Financing DealJanuary 26, 2026 | tipranks.comOrgenesis Subsidiary Secures Convertible Loan AgreementSeptember 16, 2025 | tipranks.comOrgenesis Director Ashish Nanda ResignsAugust 25, 2025 | tipranks.comSee More Orgenesis Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Orgenesis? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Orgenesis and other key companies, straight to your email. Email Address About OrgenesisOrgenesis (NASDAQ:ORGS) is a biotechnology company focused on developing and enabling cell and gene therapies. The company works on autologous cell therapies, which use a patient’s own cells, and on technologies designed to support the processing, manufacturing and delivery of these therapies. Its activities include the development of proprietary therapeutic programs and the Orgenesis POCare platform. POCare is intended to provide decentralized, point-of-care capabilities for cell and gene therapy manufacturing, helping clinical and healthcare sites produce treatments closer to the patient under controlled processes. Orgenesis was founded in 2011 and has pursued partnerships and operations across the United States, Europe and Israel. Vered Caplan, a co-founder of the company, has served as its chief executive officer. The company’s work combines therapeutic development with manufacturing infrastructure intended to support broader adoption of advanced cell and gene therapies.View Orgenesis ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Citi Stock Falls Despite Earnings Beat: What Investors Need to KnowDon’t Get NVIDIA’s Reflection AI Interest Wrong: Its Moat Could DeepenIREN Limited's AI Pivot Gains Traction—But Can Its Data Centers Deliver?PBF Energy's Stunning Rally Faces a Critical TestA Chinese Rival Just Spooked Memory Stocks—How Worried Should Micron Investors Be?Albertsons Is Betting on a Turnaround—But Will It Pay Off?PepsiCo's Earnings Beat Masks a Bigger Problem With Its North American Business Upcoming Earnings Interactive Brokers Group (10/15/2026)Marsh & McLennan Companies (10/15/2026)The PNC Financial Services Group (10/15/2026)Charles Schwab (10/15/2026)U.S. Bancorp (10/15/2026)Prologis (10/15/2026)Taiwan Semiconductor Manufacturing (10/15/2026)Truist Financial (10/16/2026)Travelers Companies (10/16/2026)HDFC Bank (10/17/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
